Meeder Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Meeder Asset Management's IONS Position: Q3 2026 in Review
Meeder Asset Management increased its Ionis Pharmaceuticals (IONS) stake by 113% in Q3 2026, buying an estimated $4.6K and bringing the position to 153 shares worth $6.83K. The position accounts for ﹤0.01% of the portfolio, ranked #773.
Meeder Asset Management first reported a position in IONS in Q4 2016 and has held it in 26 quarters since. The position peaked at $219K in Q4 2019. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- Meeder Asset Management held 153 shares of Ionis Pharmaceuticals worth $6.83K as of Q3 2026.
- Meeder Asset Management bought 81 Ionis Pharmaceuticals shares in Q3 2026, an estimated $4.6K.
- Ionis Pharmaceuticals made up ﹤0.01% of Meeder Asset Management's portfolio in Q3 2026, its #773 holding.
- Meeder Asset Management first reported a position in Ionis Pharmaceuticals in Q4 2016 and has held it in 26 quarters since.
- Meeder Asset Management's Ionis Pharmaceuticals position peaked at $219K in Q4 2019.
- 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on Meeder Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.